These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34505459)

  • 1. Emerging contributions of formyl peptide receptors to neurodegenerative diseases.
    Busch L; Vieten S; Brödel S; Endres K; Bufe B
    Biol Chem; 2022 Jan; 403(1):27-41. PubMed ID: 34505459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unleashing the power of formyl peptide receptor 2 in cardiovascular disease.
    Prevete N; Poto R; Marone G; Varricchi G
    Cytokine; 2023 Sep; 169():156298. PubMed ID: 37454543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Inflammation and Oxidative Stress by Formyl Peptide Receptors in Cardiovascular Disease Progression.
    Caso VM; Manzo V; Pecchillo Cimmino T; Conti V; Caso P; Esposito G; Russo V; Filippelli A; Ammendola R; Cattaneo F
    Life (Basel); 2021 Mar; 11(3):. PubMed ID: 33804219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Formyl Peptide Receptors in Neurological Diseases via Regulating Inflammation.
    Zhu J; Li L; Ding J; Huang J; Shao A; Tang B
    Front Cell Neurosci; 2021; 15():753832. PubMed ID: 34650406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotactic Ligands that Activate G-Protein-Coupled Formylpeptide Receptors.
    Krepel SA; Wang JM
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formyl Peptide Receptors in Cellular Differentiation and Inflammatory Diseases.
    Lee HY; Lee M; Bae YS
    J Cell Biochem; 2017 Jun; 118(6):1300-1307. PubMed ID: 28075050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition.
    He HQ; Ye RD
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28335409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Contribution of Chemoattractant GPCRs, Formylpeptide Receptors, to Inflammation and Cancer.
    Liang W; Chen K; Gong W; Yoshimura T; Le Y; Wang Y; Wang JM
    Front Endocrinol (Lausanne); 2020; 11():17. PubMed ID: 32038501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleiotropic roles of formyl peptide receptors.
    Le Y; Oppenheim JJ; Wang JM
    Cytokine Growth Factor Rev; 2001 Mar; 12(1):91-105. PubMed ID: 11312121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular biology for formyl peptide receptors in human diseases.
    Li Y; Ye D
    J Mol Med (Berl); 2013 Jul; 91(7):781-9. PubMed ID: 23404331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonists.
    Cattaneo F; Parisi M; Ammendola R
    Int J Mol Sci; 2013 Apr; 14(4):7193-230. PubMed ID: 23549262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The
    Cussell PJG; Gomez Escalada M; Milton NGN; Paterson AWJ
    Neural Regen Res; 2020 Jul; 15(7):1191-1198. PubMed ID: 31960798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formyl Peptide Receptor (FPR)1 Modulation by Resveratrol in an LPS-Induced Neuroinflammatory Animal Model.
    Calvello R; Cianciulli A; Porro C; Moda P; De Nuccio F; Nicolardi G; Giannotti L; Panaro MA; Lofrumento DD
    Nutrients; 2021 Apr; 13(5):. PubMed ID: 33922475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of formyl peptide receptors (FPR) in abnormal inflammation responses involved in neurodegenerative diseases.
    Mollica A; Stefanucci A; Costante R; Pinnen F
    Antiinflamm Antiallergy Agents Med Chem; 2012; 11(1):20-36. PubMed ID: 22934745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic characteristics of the neutrophil receptors that recognize formylated peptides, a danger-associated molecular pattern generated by bacteria and mitochondria.
    Dahlgren C; Gabl M; Holdfeldt A; Winther M; Forsman H
    Biochem Pharmacol; 2016 Aug; 114():22-39. PubMed ID: 27131862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and conformational studies of biased agonism through formyl peptide receptors.
    Liao Q; Ye RD
    Am J Physiol Cell Physiol; 2022 May; 322(5):C939-C947. PubMed ID: 35385323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.
    Ye RD; Boulay F; Wang JM; Dahlgren C; Gerard C; Parmentier M; Serhan CN; Murphy PM
    Pharmacol Rev; 2009 Jun; 61(2):119-61. PubMed ID: 19498085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biased perspectives on formyl peptide receptors.
    Raabe CA; Gröper J; Rescher U
    Biochim Biophys Acta Mol Cell Res; 2019 Feb; 1866(2):305-316. PubMed ID: 30521870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses.
    Migeotte I; Communi D; Parmentier M
    Cytokine Growth Factor Rev; 2006 Dec; 17(6):501-19. PubMed ID: 17084101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Contribution of Formyl Peptide Receptor Dysfunction to the Course of Neuroinflammation: A Potential Role in the Brain Pathology.
    Trojan E; Bryniarska N; Leśkiewicz M; Regulska M; Chamera K; Szuster-Głuszczak M; Leopoldo M; Lacivita E; Basta-Kaim A
    Curr Neuropharmacol; 2020; 18(3):229-249. PubMed ID: 31629396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.